|
|
|
Scientific Literature, albumin
-
Abrahamian H, Endler G, Exner M, Mauler H, Raith M, Endler L, Rumpold H, Gerdov M, Mannhalter C, Prager R, Irsigler K, Wagner OF 2007 Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines.
Exp. Clin. Endocrinol. Diabetes 115: 38-41.
-
Abrams GA, Concato J, Fallon MB 1996 Muscle cramps in patients with cirrhosis.
Am. J. Gastroenterol. 91: 1363-1366.
-
Acevedo Ribo M, Moreno Planas JM, Sanz Moreno C, Rubio Gonzalez EE, Rubio Gonzalez E, Boullosa Grana E, Sanchez-Turrion V, Sanz Guajardo D, Cuervas-Mons V 2005 Therapy of intractable pruritus with MARS.
Transplant. Proc. 37: 1480-1481.
*
-
Adams LA, Zein CO, Angulo P, Lindor KD 2004 A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.
Am. J. Gastroenterol. 99: 2365-2368.
*
-
Ahishali E, Pinarbasi B, Akyuz F, Ibrisim D, Kaymakoglu S, Mungan Z 2007 A case of Aeromonas hydrophila enteritis in the course of ulcerative colitis.
Eur. J. Intern. Med. 18: 430-431.
-
Ahmed N, Thornalley PJ, Luthen R, Haussinger D, Sebekova K, Schinzel R, Voelker W, Heidland A 2004 Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosis.
J. Hepatol. 41: 913-919.
*
-
Ai Y, Liu SY, Yao Q 2004 Clinical characteristics of 1241 cases of intrahepatic cholestasis of pregnancy.
Zhonghua Fu Chan Ke Za Zhi 39: 217-220.
-
Aimbire F, Albertini R, Pacheco MT, Castro-Faria-Neto HC, Leonardo PS, Iversen VV, Lopes-Martins RA, Bjordal JM 2006 Low-level laser therapy induces dose-dependent reduction of TNFalpha levels in acute inflammation.
Photomed. Laser Surg. 24: 33-37.
-
Aires V, Hichami A, Moutairou K, Khan NA 2003 Docosahexaenoic acid and other fatty acids induce a decrease in pHi in Jurkat T-cells.
Br. J. Pharmacol. 140: 1217-1226.
*
-
Aithal GP, Ramsay L, Daly AK, Sonchit N, Leathart JBS, Alexander G, Kenna JG, Caldwell J, Day CP 2004 Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.
Hepatology 39: 1430-1440.
*
-
Akcay A, Ozdemir FN, Sezer S, Micozkadioglu H, Arat Z, Atac FB, Verdi H, Sahin F, Haberal M 2005 Association of vitamin D receptor gene polymorphisms with hypercalcemia in peritoneal dialysis patients.
Perit. Dial. Int. 25 Suppl. 3: S52-S55.
-
Akerman PA, Jenkins RL, Bistrian BR 1993 Preoperative nutrition assessment in liver transplantation.
Nutrition 9: 350-356.
-
Akman SA, Arikan C, Sozen G, Ozturk C, Yagci RV 2006 Infliximab treatment of pediatric refractory Crohn's disease: a case report.
Turk. J. Gastroenterol. 17: 133-136.
*
-
Aksungar FB, Topkaya AE, Yildiz Z, Sahin S, Turk U 2008 Coagulation status and biochemical and inflammatory markers in multiple sclerosis.
J. Clin. Neurosci. 15: 393-397.
-
Al-Kateb H, Mirea L, Xie X, Sun L, Liu M, Chen H, Bull SB, Boright AP, Paterson AD 2007 Multiple variants in vascular endothelial growth factor (VEGF) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study.
Diabetes 56: 2161-2168.
*
-
Al-Toma A, Goerres MS, Meijer JW, von Blomberg BM, Wahab PJ, Kerckhaert JA, Mulder CJ 2006 Cladribine therapy in refractory celiac disease with aberrant T cells.
Clin. Gastroenterol. Hepatol. 4: 1322-1327.
-
Albano E, Mottaran E, Vidali M, Reale E, Saksena S, Occhino G, Burt AD, Day CP 2005 Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis.
Gut 54: 987-993.
*
-
Albrecht C, Meijer DK, Lebbe C, Sagesser H, Melgert BN, Poelstra K, Reichen J 1997 Targeting naproxen coupled to human serum albumin to nonparenchymal cells reduces endotoxin-induced mortality in rats with biliary cirrhosis.
Hepatology 26: 1553-1559.
*
-
Aldamiz-Echevarria L, Vallo A, Aguirre M, Sanjurjo P, Gonzalez-Lamuno D, Elorz J, Prieto JA, Andrade F, Rodriguez-Soriano J 2007 Essential fatty acid deficiency profile in patients with nephrotic-range proteinuria.
Pediatr. Nephrol. 22: 533-540.
*
-
Aleksandra Nielsen A, Nederby Nielsen J, Schmedes A, Brandslund I, Hey H 2005 Saliva interleukin-6 in patients with inflammatory bowel disease.
Scand. J. Gastroenterol. 40: 1444-1448.
*
-
Alenmyr L, Matheu V, Uller L, Greiff L, Malm-Erjefalt M, Ljunggren HG, Persson CG, Korsgren M 2005 Blockade of CTLA-4 promotes airway inflammation in naive mice exposed to aerosolized allergen but fails to prevent inhalation tolerance.
Scand. J. Immunol. 62: 437-444.
*
-
Aleryani SL, Cluette-Brown JE, Khan ZA, Hasaba H, Lopez de Heredia L, Laposata M 2005 Fatty acid methyl esters are detectable in the plasma and their presence correlates with liver dysfunction.
Clin. Chim. Acta 359: 141-149.
*
-
Alhan E, Turkyilmaz S, Ercin C, Kaklikkaya N, Kural BV 2006 Effects of omega-3 fatty acids on acute necrotizing pancreatitis in rats.
Eur. Surg. Res. 38: 314-321.
-
Alnounou M, Munoz SJ 2006 Nutrition Issues In Gastroenterology, Series #37. Nutrition concerns of the patient with primary biliary cirrhosis or primary sclerosing cholangitis. [http://www.healthsystem.virginia.edu/internet/digestive-health/nutritionarticles/April2006.pdf]
Practical Gastroenterology April 2006: 92-100. *
-
Alonso C, Guilarte M, Vicario M, Ramos L, Ramadan Z, Antolin M, Martinez C, Rezzi S, Saperas E, Kochhar S, Santos J, Malagelada JR 2008 Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation.
Gastroenterology 135: 163-172.e1.
*
-
Alonso L AG 2006 Effect of pregnancy on pre-existing liver disease physiological changes during pregnancy.
Ann. Hepatol. 5: 184-186.
*
-
Alvarez F 2004 Clinical and diagnostics aspects in children.
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 87-88. *
-
Alves A, Panis Y, Mathieu P, Mantion G, Kwiatkowski F, Slim K; Association Francaise de Chirurgie 2005 Postoperative mortality and morbidity in French patients undergoing colorectal surgery: results of a prospective multicenter study.
Arch. Surg. 140: 278-283.
*
-
Alzahrani AS, Sheef MA 2008 Severe primary hyperparathyroidism masked by asymptomatic celiac disease.
Endocr. Pract. 14: 347-350.
-
Amano K, Leung PS, Xu Q, Marik J, Quan C, Kurth MJ, Nantz MH, Ansari AA, Lam KS, Zeniya M, Coppel RL, Gershwin ME 2004 Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible.
J. Immunol. 172: 6444-6452.
*
-
Ambinder EP, Cohen LB, Wolke AM, Field SP, Adelsberg B, Schaffner F, Zaroulis CG 1985 The clinical effectiveness and safety of chronic plasmapheresis in patients with primary biliary cirrhosis.
J. Clin. Apheresis 2: 219-223.
-
Ammon HP 2006 Boswellic acids in chronic inflammatory diseases.
Planta Med. 72: 1100-1116.
-
An Y, Xiao YB 2007 Growth hormone prevents acute liver injury induced by cardiopulmonary bypass in a rat model.
J. Thorac. Cardiovasc. Surg. 134: 342-350.
-
Andersen HU, Lanng S, Pressler T, Laugesen CS, Mathiesen ER 2006 Cystic fibrosis-related diabetes: the presence of microvascular diabetes complications.
Diabetes Care 29: 2660-2663.
-
Anderson CL, Chaudhury C, Kim J, Bronson CL, Wani MA, Mohanty S 2006 Perspective - FcRn transports albumin: relevance to immunology and medicine.
Trends Immunol. 27: 343-348.
*
-
Anderson MJ, Fritsche KL 2004 Dietary polyunsaturated fatty acids modulate in vivo, antigen-driven CD4+ T-cell proliferation in mice.
J. Nutr. 134: 1978-1983.
*
-
Andrade MC, Menezes JS, Cassali GD, Martins-Filho OA, Cara DC, Faria AM 2006 Alcohol-induced gastritis prevents oral tolerance induction in mice.
Clin. Exp. Immunol. 146: 312-322.
*
-
Andres A, Toso C, Morel P, Demuylder-Mischler S, Bosco D, Baertschiger R, Pernin N, Bucher P, Majno PE, Buhler LH, Berney T 2005 Impact of a sirolimus/tacrolimus-based immunosuppressive regimen on kidney function after islet transplantation.
Transplant. Proc. 37: 1326-1327.
*
-
Angeli P, Albino G, Carraro P, Dalla Pria M, Merkel C, Caregaro L, De Bei E, Bortoluzzi A, Plebani M, Gatta A 1996 Cirrhosis and muscle cramps: evidence of a causal relationship.
Hepatology 23: 264-273.
*
-
Angulo P, Jorgensen RA, Kowdley KV, Lindor KD 2008 Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study.
Dig. Dis. Sci. 53: 1716-1720.
*
-
Angulo P, Jorgensen RA, Lindor KD 2001 Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?
Am. J. Gastroenterol. 96: 3152-3157.
*
-
Angulo P, Patel T, Jorgensen RA, Therneau TM, Lindor KD 2000 Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Hepatology 32: 897-900.
*
-
Anic K, Ivandic A, Peric L, Fijacko M, Volaric M, Bacun T, Kovacic D, Getto L 1999 Isoenzymes of gammaglutamyltransferase in patients with obstructive and hepatocellular icterus.
Wien. Med. Wochenschr. 149: 359-363.
-
Anomasiri WT, Tovell DR, Tyrrell DL 1990 Paramyxovirus membrane protein enhances antibody production to new antigenic determinants in the actin molecule: a model for virus-induced autoimmunity.
J. Virol. 64: 3179-3184.
*
-
Antignac M, Hulot JS, Boleslawski E, Hannoun L, Touitou Y, Farinotti R, Lechat P, Urien S 2005 Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance.
Eur. J. Clin. Pharmacol. 61: 409-416.
*
-
Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S 2008 Generation of pluripotent stem cells from adult mouse liver and stomach cells.
Science 321: 699-702.
*
-
Aoki H, Hisada T, Ishizuka T, Utsugi M, Kawata T, Shimizu Y, Okajima F, Dobashi K, Mori M 2008 Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma.
Biochem. Biophys. Res. Commun. 367: 509-515.
*
-
Aoki T, Umehara Y, Ferraresso C, Sugiyama N, Middleton Y, Avital I, Inderbitzin D, Demetriou AA, Rozga J 2002 Intrasplenic transplantation of encapsulated cells: a novel approach to cell therapy.
Cell Transplant. 11: 553-561.
-
Arikura J, Inagaki M, Huiling X, Ozaki A, Onodera K, Ogawa K, Kasai S 2004 Colonization of albumin-producing hepatocytes derived from transplanted F344 rat bone marrow cells in the liver of congenic Nagase's analbuminemic rats.
J. Hepatol. 41: 215-221.
*
-
Arroyo V 2002 Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
Ann. Hepatol. 1: 72-79.
*
-
Arroyo V, Colmenero J 2003 Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict.
Dig. Liver Dis. 35: 668-672.
-
Arroyo V, Terra C, Gines P 2006 New treatments of hepatorenal syndrome.
Semin. Liver Dis. 26: 254-264.
-
Arslan N, Buyukgebiz B, Ozturk Y, Ozer E 2005 The prevalence of liver function abnormalities in pediatric celiac disease patients and its relation with intestinal biopsy findings.
Acta Gastroenterol. Belg. 68: 424-427.
-
Arulventhan R, Larcos G, Gruenewald S, Farrell G 2006 Primary sclerosing cholangitis: correlation of hepatobiliary scintigraphy with clinical and laboratory status.
Australas. Radiol. 50: 330-334.
-
Askari FK, Greenson J, Dick RD, Johnson VD, Brewer GJ 2003 Treatment of Wilson's disease with zinc. XVIII. Initial treatment of the hepatic decompensation presentation with trientine and zinc.
J. Lab. Clin. Med. 142: 385-390.
*
-
Asquith DL, McInnes IB 2007 Emerging cytokine targets in rheumatoid arthritis.
Curr. Opin. Rheumatol. 19: 246-251.
-
Auci D, Nicoletti F, Mangano K, Pieters R, Nierkens S, Morgan L, Offner H, Frincke J, Reading C 2005 Anti-inflammatory and immune regulatory properties of 5-androsten-3beta, 17beta-diol (HE2100), and synthetic analogue HE3204: implications for treatment of autoimmune diseases.
Ann. N. Y. Acad. Sci. 1051: 730-742.
-
Aurich I, Mueller LP, Aurich H, Luetzkendorf J, Tisljar K, Dollinger M, Schormann W, Walldorf J, Hengstler J, Fleig WE, Christ B 2007 Functional integration of human mesenchymal stem cell-derived hepatocytes into mouse livers.
Gut 56: 405-415.
*
-
Auth MK, Kim HS, Beste M, Bonzel KE, Baumann U, Ballauff A, Wallot M, Borchers T, Vester U, Grasemann C, Hauffa B, Hoyer PF, Gerken G, Voit T 2005 Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children.
J. Pediatr. Gastroenterol. Nutr. 40: 54-59.
*
-
Auth MK, Woitaschek D, Beste M, Schreiter T, Kim HS, Oppermann E, Joplin RE, Baumann U, Hilgard P, Nadalin S, Markus BH, Blaheta RA 2005 Preservation of the synthetic and metabolic capacity of isolated human hepatocytes by coculture with human biliary epithelial cells.
Liver Transpl. 11: 410-419.
*
-
Aviles J, Macia M, Morales S, Perez F, Moreno A, Navarro J, Navazo L, Garcia J 2001 Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain.
Nefrologia 21: 376-385.
-
Azer SA, Coverdale SA, Byth K, Farrell GC, Stacey NH 1996 Sequential changes in serum levels of individual bile acids in patients with chronic cholestatic liver disease.
J. Gastroenterol. Hepatol. 11: 208-215.
-
Azzolini F, Pagnini C, Camellini L, Scarcelli A, Merighi A, Primerano AM, Bertani A, Antonioli A, Manenti F, Rigo GP 2005 Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis.
Dig. Dis. Sci. 50: 246-251.
*
-
Backer R, van Leeuwen F, Kraal G, den Haan JM 2008 CD8(-) dendritic cells preferentially cross-present Saccharomyces cerevisiae antigens.
Eur. J. Immunol. 38: 370-380.
*
-
Baharvand H, Hashemi SM, Shahsavani M 2008 Differentiation of human embryonic stem cells into functional hepatocyte-like cells in a serum-free adherent culture condition.
Differentiation 76: 465-477.
-
Bakula A, Socha P, Pawlowska J, Teisseyre M, Jankowska I, Kalicinski P 2007 Good and bad prognosis of alpha-1-antitrypsin deficiency in children: when to list for liver transplantation.
Transplant. Proc. 39: 3186-3188.
*
-
Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER 1990 Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study.
Gastroenterology 98: 1567-1571.
-
Balistreri WF 2003 Genetic liver disease.
54th Annual Meeting of the American Association for the Study of Liver Diseases.
-
Baluyut AR, Sherman S, Lehman GA, Hoen H, Chalasani N 2001 Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis.
Gastrointest. Endosc. 53: 308-312.
*
-
Banares Canizares R, Catalina Rodriguez MV 2003 Indications and therapeutic possibilities of albumin dialysis (MARS).
Rev. Esp. Enferm. Dig. 95: 876-889.
-
Banares R, Albillos A, Catalina MV 2008 Which is the best way to analyze the efficacy of albumin dialysis in hepatic encephalopathy?
Hepatology 48: 686-687.
-
Bankar RN, Dafe CO, Kohnke A, Babu PS 2006 Ulcerative colitis probably associated with isotretinoin.
Indian J. Gastroenterol. 25: 171-172.
*
-
Bao S, Beagley KW, Murray AM, Caristo V, Matthaei KI, Young IG, Husband AJ 1998 Intestinal IgA plasma cells of the B1 lineage are IL-5 dependent.
Immunology 94: 181-188.
*
-
Barbosa DS, Cecchini R, El Kadri MZ, Rodriguez MA, Burini RC, Dichi I 2003 Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids.
Nutrition 19: 837-842.
*
-
Baric I, Fumic K, Glenn B, Cuk M, Schulze A, Finkelstein JD, James SJ, Mejaski-Bosnjak V, Pazanin L, Pogribny IP, Rados M, Sarnavka V, Scukanec-Spoljar M, Allen RH, Stabler S, Uzelac L, Vugrek O, Wagner C, Zeisel S, Mudd SH 2004 S-Adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism.
Proc. Natl. Acad. Sci. U.S.A. 101: 4234-4239.
*
-
Barnes BH, Borowitz SM, Saulsbury FT, Hellems M, Sutphen JL 2004 Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
J. Pediatr. Gastroenterol. Nutr. 38: 509-512.
*
-
Barry PJ, Waterhouse DF, Reilly CM, McKenna TJ, McKone EF, Gallagher CG 2008 Androgens, exercise capacity and muscle function in cystic fibrosis.
Chest Aug 8 [Epub ahead of print].
-
Bastien MC, Leblond F, Pichette V, Villeneuve JP 2000 Differential alteration of cytochrome P450 isoenzymes in two experimental models of cirrhosis.
Can. J. Physiol. Pharmacol. 78: 912-919.
-
Battezzati PM, Podda M, Bianchi FB, Naccarato R, Orlandi F, Surrenti C, Pagliaro L, Manenti F 1993 Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC.
J. Hepatol. 17: 332-338.
-
Baumer W, Hoppmann J, Rundfeldt C, Kietzmann M 2007 Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis.
Inflamm. Allergy Drug Targets 6: 17-26.
-
Bayliss M, Somers G 2004 Isolation and culture of human hepatocytes.
Methods Mol. Med. 107: 249-268.
-
Beaugerie L, Thiefin G 2004 Gastrointestinal complications related to NSAIDs.
Gastroenterol. Clin. Biol. 28 Spec. No 3: C62-C72.
-
Beckebaum S, Cicinnati V, Broelsch CE 2003 Liver transplantation, rejection and disease recurrence.
Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 55-56. October 15-16. *
-
Becker A, Smulders YM, van Guldener C, Stehouwer CD 2003 Epidemiology of homocysteine as a risk factor in diabetes.
Metab. Syndr. Relat. Disord. 1: 105-120.
-
Becker J, Delayre-Orthez C, Frossard N, Pons F 2008 Regulation of peroxisome proliferator-activated receptor-alpha expression during lung inflammation.
Pulm. Pharmacol. Ther. 21: 324-330.
-
Beckett CG, Dell'Olio D, Shidrawi RG, Rosen-Bronson S, Ciclitira PJ 1999 Gluten-induced nitric oxide and pro-inflammatory cytokine release by cultured coeliac small intestinal biopsies.
Eur. J. Gastroenterol. Hepatol. 11: 529-535.
-
Bedi MK 2007 Successful treatment of long-standing, recalcitrant subcorneal pustular dermatosis with etanercept.
Skinmed. 6: 245-247.
-
Bellmann R, Graziadei IW, Feistritzer C, Schwaighofer H, Stellaard F, Sturm E, Wiedermann CJ, Joannidis M 2004 Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysis.
Liver Transpl. 10: 107-114.
*
-
Bellomo-Brandao MA, Porta G, Hessel G 2008 Clinical and laboratory evaluation of 101 patients with intrahepatic neonatal cholestasis.
Arq. Gastroenterol. 45: 152-155.
*
-
Ben-Ari Z, Weiss-Schmilovitz H, Sulkes J, Brown M, Bar-Nathan N, Shaharabani E, Yussim A, Shapira Z, Tur-Kaspa R, Mor E 2004 Serum cholestasis markers as predictors of early outcome after liver transplantation.
Clin. Transplant. 18: 130-136.
-
Benabdeslam H, Garcia I, Bellon G, Gilly R, Revol A 1998 Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts.
Am. J. Clin. Nutr. 67: 912-918.
*
-
Beraza N, Ludde T, Assmus U, Roskams T, Borght SV, Trautwein C 2007 Hepatocyte-specific IKKgamma/NEMO expression determines the degree of liver injury.
Gastroenterology 132: 2504-2517.
*
-
Berbaum K, Shanmugam K, Stuchbury G, Wiede F, Korner H, Munch G 2008 Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array.
Cytokine 41: 198-203.
-
Bergasa NV 2004 Pruritus in chronic liver disease: mechanisms and treatment.
Curr. Gastroenterol. Rep. 6: 10-16.
-
Bergasa NV 2005 The pruritus of cholestasis.
J. Hepatol. 43: 1078-1088.
*
-
Bergasa NV, Mason A, Floreani A, Heathcote J, Swain MG, Jones DE, Lindor KM, Bassendine MF, Worman HJ 2004 Primary biliary cirrhosis: report of a focus study group.
Hepatology 40: 1013-1020.
*
-
Bertolino P, Bowen DG, Zen M, Holz L, Davis T, McCaughan GW 2004 Hepatocytes as targets of autoreactivity.
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 33. *
-
Bessa SS, Hamdy SM, Ali EM 2007 Haptoglobin gene polymorphism in type 2 diabetic patients with and without nephropathy: an Egyptian study.
Eur. J. Intern. Med. 18: 489-495.
-
Beukers R, van Zanten RA, Schalm SW 1992 Serial determination of type III procollagen amino propeptide serum levels in patients with histologically progressive and non-progressive primary biliary cirrhosis.
J. Hepatol. 14: 22-29.
-
Bird JE, Giancarli MR, Kurihara T, Kowala MC, Valentine MT, Gitlitz PH, Pandya DG, French MH, Durham SK 2000 Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice.
Kidney Int. 57: 129-136.
*
-
Birketvedt GS, Berg KJ, Fausa O, Florholmen J 2000 Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis.
Inflamm. Bowel Dis. 6: 275-279.
*
-
Bissig KD, Le TT, Woods NB, Verma IM 2007 Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model.
Proc. Natl. Acad. Sci. U.S.A. 104: 20507-20511.
*
-
Bjarnason I, Macpherson AJ 1994 Intestinal toxicity of non-steroidal anti-inflammatory drugs.
Pharmacol. Ther. 62: 145-157.
-
Blei AT 2004 Albumin dialysis for the treatment of hepatic encephalopathy.
J. Gastroenterol. Hepatol. 19: S224-S228. *
-
Blendis L, Wong F 1999 Intravenous albumin with diuretics: protean lessons to be learnt?
J. Hepatol. 30: 727-730.
*
-
Boberg KM, Rocca G, Egeland T, Bergquist A, Broome U, Caballeria L, Chapman R, Hultcrantz R, Mitchell S, Pares A, Rosina F, Schrumpf E 2002 Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.
Hepatology 35: 652-657.
*
-
Boberg KM, Schrumpf E 2004 Prognosis of autoimmune liver diseases.
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, p. 81. *
-
Boehm D, Krzystek-Korpacka M, Neubauer K, Matusiewicz M, Berdowska I, Zielinski B, Paradowski L, Gamian A 2008 Paraoxonase-1 status in Crohn's disease and ulcerative colitis.
Inflamm. Bowel Dis. Jul 14 [Epub ahead of print].
-
Boger CA, Stubanus M, Haak T, Gotz AK, Christ J, Hoffmann U, Riegger GA, Kramer BK 2007 Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.
Nephrol. Dial. Transplant. 22: 154-162.
-
Borini P, Guimaraes RC 2003 Noninvasive classification of liver disease in asymptomatic and oligosymptomatic male alcoholics.
Braz. J. Med. Biol. Res. 36: 1367-1373.
*
-
Bosch T 2005 Therapeutic apheresis - state of the art in the year 2005.
Ther. Apher. Dial. 9: 459-468.
*
-
Bousvaros A, Zurakowski D, Duggan C, Law T, Rifai N, Goldberg NE, Leichtner AM 1998 Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity.
J. Pediatr. Gastroenterol. Nutr. 26: 129-135.
-
Bouwman LH, Roos A, Terpstra OT, de Knijff P, van Hoek B, Verspaget HW, Berger SP, Daha MR, Frolich M, van der Slik AR, Doxiadis II, Roep BO, Schaapherder AF 2005 Mannose binding lectin gene polymorphisms confer a major risk for severe infections after liver transplantation.
Gastroenterology 129: 408-414.
*
-
Brant PE, Kopke-Aguiar L, Shigueoka DC, Sales D, D'Ippolito G, Kouyoumdjian M, Borges DR 2008 Anicteric cholangiopathy in schistosomiasis patients.
Acta Trop. Jun 11 [Epub ahead of print].
-
Branten AJ, Swinkels DW, Klasen IS, Wetzels JF 2004 Serum ferritin levels are increased in patients with glomerular diseases and proteinuria.
Nephrol. Dial. Transplant. 19: 2754-2760.
*
-
Brar P, Kwon GY, Holleran S, Bai D, Tall AR, Ramakrishnan R, Green PH 2006 Change in lipid profile in celiac disease: beneficial effect of gluten-free diet.
Am. J. Med. 119: 786-790.
*
-
Bressler B, Pinto R, El-Ashry D, Heathcote EJ 2005 Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
Gut 54: 407-410.
*
-
Brinch L, Teisberg P, Schrumpf E, Akesson I 1982 The in vivo metabolism of C3 in hepatobiliary disease associated with ulcerative colitis.
Scand. J. Gastroenterol. 17: 523-527.
-
Brinson RR, Curtis WD, Schuman BM, Mills LR 1988 Recovery from hepatic vein thrombosis (Budd-Chiari syndrome) complicating ulcerative colitis.
Dig. Dis. Sci. 33: 1615-1620.
-
Brito MA, Lima S, Fernandes A, Falcao AS, Silva RF, Butterfield DA, Brites D 2008 Bilirubin injury to neurons: contribution of oxidative stress and rescue by glycoursodeoxycholic acid.
Neurotoxicology 29: 259-269.
-
Brock TG 2008 Capturing proteins that bind polyunsaturated fatty acids: demonstration using arachidonic acid and eicosanoids.
Lipids 43: 161-169.
-
Brodanova M, Perlik F 1997 Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.
Cas. Lek. Cesk. 136: 215-220.
-
Broome U, Eriksson LS 1994 Assessment for liver transplantation in patients with primary sclerosing cholangitis.
J. Hepatol. 20: 654-659.
-
Brostoff JM, Rashid S, McCrea D 2008 Primary biliary cirrhosis with a normal alkaline phosphatase: a case report.
Cases J. 1: 33.
*
-
Brown HJ, Lock HR, Sacks SH, Robson MG 2006 TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis.
J. Immunol. 177: 1925-1931.
*
-
Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG 2007 Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2.
J. Am. Soc. Nephrol. 18: 1732-1739.
-
Bruchfeld A, Qureshi AR, Lindholm B, Barany P, Yang L, Stenvinkel P, Tracey KJ 2008 High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD).
Mol. Med. 14: 109-115.
*
-
Bruggraber SF, Leung PS, Amano K, Quan C, Kurth MJ, Nantz MH, Benson GD, Van de Water J, Luketic V, Roche TE, Ansari AA, Coppel RL, Gershwin ME 2003 Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis.
Gastroenterology 125: 1705-1713.
*
-
Buckingham RE 2005 Thiazolidinediones: pleiotropic drugs with potent anti-inflammatory properties for tissue protection.
Hepatol. Res. 33: 167-170.
-
Buhler OT, Wiedig CA, Schmid Y, Grassl GA, Bohn E, Autenrieth IB 2006 The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses.
Infect. Immun. 74: 4322-4329.
*
-
Buning J, Hundorfean G, Schmitz M, Zimmer KP, Strobel S, Gebert A, Ludwig D 2006 Antigen targeting to MHC class II-enriched late endosomes in colonic epithelial cells: trafficking of luminal antigens studied in vivo in Crohn's colitis patients.
FASEB J. 20: 359-361.
*
-
Buning J, von Smolinski D, Tafazzoli K, Zimmer KP, Strobel S, Apostolaki M, Kollias G, Heath JK, Ludwig D, Gebert A 2008 Multivesicular bodies in intestinal epithelial cells: responsible for MHC class II-restricted antigen processing and origin of exosomes.
Immunology Aug 14 [Epub ahead of print].
*
-
Burroughs AK 2003 Is the use of albumin of value in cirrhosis? The case not so in favour, or is there an alternative?
Dig. Liver Dis. 35: 664-667.
-
Bush DA, Hillebrand DJ, Slater JM, Slater JD 2004 High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial.
Gastroenterology 127 (5 Suppl. 2): S189-S193.
*
-
Busso N, Frasnelli M, Feifel R, Cenni B, Steinhoff M, Hamilton J, So A 2007 Evaluation of protease-activated receptor 2 in murine models of arthritis.
Arthritis Rheum. 56: 101-107.
*
-
Buttenschoen K, Schneider ME, Utz K, Kornmann M, Beger HG, Carli Buttenschoen D 2008 Effect of major abdominal surgery on endotoxin release and expression of Toll-like receptors 2/4.
Langenbecks Arch. Surg. Jun 11 [Epub ahead of print].
*
-
Buxbaum J, Qian P, Allen PM, Peters MG 2008 Hepatitis resulting from liver-specific expression and recognition of self-antigen.
J. Autoimmun. May 29 [Epub ahead of print].
-
Buxbaum J, Qian P, Khuu C, Shneider BL, Daikh DI, Gershwin ME, Allen PM, Peters MG 2006 Novel model of antigen-specific induction of bile duct injury.
Gastroenterology 131: 1899-1906.
*
-
Caballeria L, Pares A, Rodes J 1999 Treatment of primary biliary cirrhosis.
Contributions to Science 1: 79-85. *
-
Cabrera-Abreu JC, Davies P, Matek Z, Murphy MS 2004 Performance of blood tests in diagnosis of inflammatory bowel disease in a specialist clinic.
Arch. Dis. Child. 89: 69-71.
*
-
Cagatay Y, Gul A, Cagatay A, Kamali S, Karadeniz A, Inanc M, Ocal L, Aral O, Konice M 2007 Adult-onset Still's disease.
Int. J. Clin. Pract. May 18 [Epub ahead of print].
-
Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC 2006 PPAR-alpha and gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.
Nephrol. Dial. Transplant. 21: 2399-2405.
-
Callado MR, Viana VS, Vendramini MB, Leon EP, Bueno C, Velosa AP, Teodoro WR, Yoshinari NH 2007 Autoantibody profile in the experimental model of scleroderma induced by type V human collagen.
Immunology 122: 38-46.
*
-
Callahan MK, Garg M, Srivastava PK 2008 Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation.
Proc. Natl. Acad. Sci. U.S.A. 105: 1662-1667.
*
-
Campard D, Lysy PA, Najimi M, Sokal EM 2008 Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells.
Gastroenterology 134: 833-848.
*
-
Campbell IW 2005 The clinical significance of PPAR gamma agonism.
Curr. Mol. Med. 5: 349-363.
-
Campbell MS, Kotlyar DS, Brensinger CM, Lewis JD, Shetty K, Bloom RD, Markmann JF, Olthoff KM, Shaked A, Reddy KR 2005 Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation.
Liver Transpl. 11: 1048-1055.
*
-
Canani LH, Capp C, Ng DP, Choo SG, Maia AL, Nabinger GB, Santos K, Crispim D, Roisemberg I, Krolewski AS, Gross JL 2005 The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patients with type 2 diabetes.
Diabetes 54: 3326-3330.
*
-
Cangemi JR, Wiesner RH, Beaver SJ, Ludwig J, MacCarty RL, Dozois RR, Zinsmeister AR, LaRusso NF 1989 Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis.
Gastroenterology 96: 790-794.
-
Cao OW, Dobrzynski E, Wang L, Nayak S, Mingle B, Terhorst CP, Herzog RW 2007 Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer.
Blood 110: 1132-1140.
*
-
Cardenas A 2005 Hepatorenal syndrome: a dreaded complication of end-stage liver disease.
Am. J. Gastroenterol. 100: 460-467.
*
-
Cardenas A, Arroyo V 2003 Hepatorenal syndrome.
Ann. Hepatol. 2: 23-29.
*
-
Carreno LJ, Bueno SM, Bull P, Nathenson SG, Kalergis AM 2007 The half-life of the T-cell receptor/peptide-major histocompatibility complex interaction can modulate T-cell activation in response to bacterial challenge.
Immunology 121: 227-237.
*
-
Casas M, Mora J, Fort E, Aracil C, Busquets D, Galter S, Jauregui CE, Ayala E, Cardona D, Gich I, Farre A 2007 Total enteral nutrition vs. total parenteral nutrition in patients with severe acute pancreatitis.
Rev. Esp. Enferm. Dig. 99: 264-269.
-
Castell JV, Larrauri A, Gomez-Lechon MJ 1988 A study of the relative hepatotoxicity in vitro of the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen and butibufen.
Xenobiotica 18: 737-745.
-
Castell LM, Yamamoto T, Phoenix J, Newsholme EA 1999 The role of tryptophan in fatigue in different conditions of stress.
Adv. Exp. Med. Biol. 467: 697-704.
-
Cavanna A, Giovine G, Tappero R, Torchio M, Avagnina P, Molino G 1985 Diagnostic value of prealbumin and retinol-binding protein in acute and chronic liver diseases.
Ric. Clin. Lab. 15: 71-77.
-
Cellini M, Versura P, Leonetti P, Frigato M, Manfredini E, Malavolta N, Campos EC 2007 Ocular surface and intraocular inflammation are related in SS-I and rheumatoid arthritis patients.
Rheumatol. Int. 27: 853-857.
*
-
Cezard JP, Nouaili N, Talbotec C, Hugot JP, Gobert JG, Schmitz J, Mougenot JF, Alberti C, Goulet O 2003 A prospective study of the efficacy and tolerance of a chimeric antibody to tumor necrosis factors (remicade) in severe pediatric Crohn disease.
J. Pediatr. Gastroenterol. Nutr. 36: 632-636.
*
-
Cha DR, Zhang X, Zhang Y, Wu J, Su DM, Han JY, Fang X, Yu B, Breyer MD, Guan Y 2007 Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
Diabetes 56: 2036-2045.
*
-
Cha S, Leung PS, Gershwin ME, Fletcher MP, Ansari AA, Coppel RL 1993 Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis.
Proc. Natl. Acad. Sci. U.S.A. 90: 2527-2531.
*
-
Chalumeau S, Moussata D, Nancey S, Claudel-Bonvoisin S, Saurin JC, Flourie B 2007 Pancytopenia induced by two low-dose injections of methotrexate in a patient treated for ulcerative colitis.
Gastroenterol. Clin. Biol. 31: 1104-1106.
-
Chan C, Berthiaume F, Washizu J, Toner M, Yarmush ML 2002 Metabolic pre-conditioning of cultured cells in physiological levels of insulin: generating resistance to the lipid-accumulating effects of plasma in hepatocytes.
Biotechnol. Bioeng. 78: 753-760.
*
-
Chan CW, Carpenter JR, Rigamonti C, Gunsar F, Burroughs AK 2005 Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: a staged prognostic model.
Scand. J. Gastroenterol. 40: 1081-1089.
*
-
Chan EP, Wells RG 2007 Today's hepatic stellate cells: not your father's sternzellen.
Hepatology 45: 1326-1327.
*
-
Chandrakasan S, Singh S, Ratho RK, Kumar S, Mishra B 2008 Anasarca as the presenting manifestation of parvovirus B19 associated juvenile dermatomyositis.
Rheumatol. Int. Sep 20 [Epub ahead of print].
-
Chang SW, Ohara N 1993 Increased pulmonary vascular permeability in rats with biliary cirrhosis: role of thromboxane A2.
Am. J. Physiol. 264: L245-L252.
-
Chang TT, Hughes-Fulford M 2008 Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes.
Tissue Eng. Part A. Aug 26 [Epub ahead of print].
-
Charatcharoenwitthaya P, Levy C, Angulo P, Keach J, Jorgensen R, Lindor KD 2007 Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis.
Liver Int. 27: 220-226.
*
-
Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS 2002 Apolipoprotein synthesis in nonalcoholic steatohepatitis.
Hepatology 35: 898-904.
*
-
Charron M 2003 Inflammatory bowel disease activity assessment with biologic markers and (99m)Tc-WBC scintigraphy: are there different trends in ileitis versus colitis?
J. Nucl. Med. 44: 1586-1591.
*
-
Chen B, Zhang Y, Liu G, Guan GJ, Hou XH, Li XG, Liu JL 2008 Effects of valsartan, mycophenolate mofetil and their combined application on TRAIL and nuclear factor-kappaB expression in the kidneys of diabetic rats.
Zhonghua Yi Xue Za Zhi 88: 540-545.
-
Chen G, Li L, Gao J, Li F, Li B 2002 Primary biliary cirrhosis: an analysis of 153 cases.
Zhonghua Yi Xue Za Zhi 82: 1625-1628.
-
Chen HL, Wang R, Chen HL, Hwu WL, Jeng YM, Chang MH, Ling V 2008 Bone marrow transplantation results in donor-derived hepatocytes in an animal model of inherited cholestatic liver disease.
J. Biomed. Sci. May 29 [Epub ahead of print].
*
-
Chen J, Raymond K 2006 Treatment effect of rifampicin on cholestasis.
The Internet Journal of Pharmacology Vol. 4 (http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijpharm/vol4n2/colestasis.xml).
-
Chen L, Fredholm BB, Jondal M 2008 Adenosine, through the A(1) receptor, inhibits vesicular MHC class I cross-presentation by resting DC.
Mol. Immunol. 45: 2247-2254.
*
-
Chen TM, Subeq YM, Lee RP, Chiou TW, Hsu BG 2008 Single dose intravenous thioacetamide administration as a model of acute liver damage in rats.
Int. J. Exp. Pathol. 89: 223-231.
-
Chen W, Gluud C 2003 Bile acids for primary sclerosing cholangitis.
Cochrane Database Syst. Rev. 2: CD003626.
*
-
Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM 2003 Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
J. Exp. Med. 198: 1875-1886.
*
-
Chen Y, Liu CP, Xu KF, Mao XD, Lu YB, Fang L, Yang JW, Liu C 2008 Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes.
Am. J. Nephrol. 28: 1014-1022.
-
Chen Y, Yang Y, Miller ML, Shen D, Shertzer HG, Stringer KF, Wang B, Schneider SN, Nebert DW, Dalton TP 2007 Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure.
Hepatology 45: 1118-1128.
*
-
Chen Z, Ding Y, Li G 2005 Configuration of a new bioartificial liver support system and in vitro evaluation of its functions.
Ann. Clin. Lab. Sci. 35: 7-14.
-
Chesner IM, Muller S, Newman J 1986 Ulcerative colitis complicated by Budd-Chiari syndrome.
Gut 27: 1096-1100.
*
-
Chiang JY 2004 Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms.
J. Hepatol. 40: 539-551.
*
-
Chida K 1990 Histochemical and immunohistochemical study on the expression of alkaline phosphatase, gamma-glutamyl transpeptidase and alpha-fetoprotein during the process of rat hepatocyte proliferation.
Kitasato Arch. Exp. Med. 63: 91-98.
-
Chiodini RJ, Van Kruiningen HJ, Merkal RS, Thayer WR Jr, Coutu JA 1984 Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease.
J. Clin. Microbiol. 20: 966-971.
*
-
Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA, Merkal RS 1984 In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn's disease.
Antimicrob. Agents Chemother. 26: 930-932.
*
-
Chiu A, Chan LM, Fan ST 2006 Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
Liver Int. 26: 695-702.
*
-
Chiu A, Fan ST 2006 MARS in the treatment of liver failure: controversies and evidence.
Int. J. Artif. Organs 29: 660-667.
-
Chiu A, Tam S, Au WY, Chan SC, Liu CL, Fan ST 2005 MARS treatment for a patient presenting with acquired hepatic glutamine synthetase deficiency after orthotopic liver transplantation.
Liver Transpl. 11: 353-355.
*
-
Cho SG, Min SY, Park MJ, Lee KW, Cho YG, Cho ML, Chang HS, Park SH, Lee JW, Min WS, Kim CC, Kim HY 2006 Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
Arthritis Rheum. 54: 1878-1887.
*
-
Choquet A, Yamamoto-Furusho JK, Reyes E, Takahashi-Monroy T, Vargas-Vorackova F, Uscanga L 2004 Predictors of colectomy in patients with ulcerative colitis. A cohort analysis of 184 cases.
Rev. Invest. Clin. 56: 11-15.
-
Choudhuri G, Somani SK, Baba CS, Alexander G 2005 Autoimmune hepatitis in India: profile of an uncommon disease.
BMC Gastroenterol. 5: 27.
*
-
Choudhury J, Sanyal AJ 2003 Treatment of ascites.
Curr. Treat. Options Gastroenterol. 6: 481-491.
-
Christakos S, Raval-Pandya M, Wernyj RP, Yang W 1996 Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.
Biochem. J. 316: 361-371.
*
-
Christen U, Quinn J, Yeaman SJ, Kenna JG, Clarke JB, Gandolfi AJ, Gut J 1994 Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis. Molecular mimicry of trifluoroacetyl-lysine by lipoic acid.
Eur. J. Biochem. 223: 1035-1047.
-
Christensen E 2003 Prognosis of untreated primary sclerosing cholangitis.
Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 63. October 15-16. *
-
Christensen E, Altman DG, Neuberger J, De Stavola BL, Tygstrup N, Williams R 1993 Updating prognosis in primary biliary cirrhosis using a time-dependent Cox regression model. PBC1 and PBC2 trial groups.
Gastroenterology 105: 1865-1876.
-
Christensen E, Gunson B, Neuberger J 1999 Optimal timing of liver transplantation for patients with primary biliary cirrhosis: use of prognostic modelling.
J. Hepatol. 30: 285-292.
*
-
Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, Doniach D, Ranek L, Tygstrup N, Williams R 1985 Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial.
Gastroenterology 89: 1084-1091.
-
Chung H, Kudo M, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y 2006 A proposal of the modified liver damage classification for hepatocellular carcinoma.
Hepatol. Res. 34: 124-129.
-
Ciacci C, Cirillo M, Cavallaro R, Mazzacca G 2002 Long-term follow-up of celiac adults on gluten-free diet: prevalence and correlates of intestinal damage.
Digestion 66: 178-185.
-
Ciccocioppo R, Rossi M, Pesce I, Ricci G, Millimaggi D, Maurano F, Corazza GR 2008 Effects of gliadin stimulation on bone marrow-derived dendritic cells from HLA-DQ8 transgenic MICE.
Dig. Liver Dis. Jun 20 [Epub ahead of print].
-
Cifelli CJ, Ross AC 2006 All-trans-retinoic acid distribution and metabolism in vitamin A-marginal rats.
Am. J. Physiol. Gastrointest. Liver Physiol. 291: G195-G202.
*
-
Cigliano L, Maresca B, Salvatore A, Nino M, Monfrecola G, Ayala F, Carlucci A, Pugliese RC, Pedone C, Abrescia P 2008 Haptoglobin from psoriatic patients exhibits decreased activity in binding haemoglobin and inhibiting lecithin-cholesterol acyltransferase activity.
J. Eur. Acad. Dermatol. Venereol. 22: 417-425.
*
-
Clark WF, Parbtani A, Huff MW, Reid B, Holub BJ, Falardeau P 1989 Omega-3 fatty acid dietary supplementation in systemic lupus erythematosus.
Kidney Int. 36: 653-660.
-
Clayton RF, Rinaldi A, Kandyba EE, Edward M, Willberg C, Klenerman P, Patel AH 2005 Liver cell lines for the study of hepatocyte functions and immunological response.
Liver Int. 25: 389-402.
*
-
Codolo G, Mazzi P, Amedei A, Del Prete G, Berton G, D'Elios MM, de Bernard M 2008 The neutrophil activating protein of Helicobacter pylori down-modulates Th2 inflammation in OVA-induced allergic asthma.
Cell. Microbiol. Jul 29 [Epub ahead of print].
*
-
Cohran VC, Heubi JE 2003 Treatment of pediatric cholestatic liver disease.
Curr. Treat. Options Gastroenterol. 6: 403-415.
-
Cojocaru VM, Ciurtin C, Puchianu E, Anothe F 2006 Electroforetic analysis of lacrimal proteins - diagnostic method in secondary Sjogren syndrome.
Oftalmologia 50: 3-5.
-
Cojocaru VM, Ciurtin C, Puchianu E, Antohe F 2006 Lacrimal proteins electrophoretic analysis - diagnostic method in secondary Sjogren syndrome.
Oftalmologia 50: 60-63.
-
Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A 1996 Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis.
Hepatology 23: 1484-1490.
*
-
Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS 2007 The clinical effectiveness and cost-effectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review.
Health Technol. Assess. 11: 1-112.
*
-
Combes B, Emerson SS, Flye NL, Munoz SJ, Luketic VA, Mayo MJ, McCashland TM, Zetterman RK, Peters MG, Di Bisceglie AM, Benner KG, Kowdley KV, Carithers Jr RL, Rosoff Jr L, Garcia-Tsao G, Boyer JL, Boyer TD, Martinez EJ, Bass NM, Lake JR, et al 2005 Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
Hepatology 42: 1184-1193.
*
-
Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, Castilla-Cortazar I, Frystyk J, Flyvbjerg A, Yoshizawa C, Jansen PL, Scharschmidt B, Prieto J 2005 Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial.
J. Hepatol. 43: 630-636.
*
-
Cone RE, Li X, Sharafieh R, O'Rourke J, Vella AT 2007 The suppression of delayed-type hypersensitivity by CD8 regulatory T cells requires interferon-gamma.
Immunology 120: 112-119.
*
-
Connolly AK, Price SC, Connelly JC, Hinton RH 1988 Early changes in bile duct lining cells and hepatocytes in rats treated with alpha-naphthylisothiocyanate.
Toxicol. Appl. Pharmacol. 93: 208-219.
-
Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM, Hancock LN, Cleary PA, Mueller PW 2008 Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study.
Diabetes 57: 518-522.
-
Corpechot C, Carrat F, Poupon R, Poupon RE 2002 Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients.
Gastroenterology 122: 652-658.
*
-
Costa C, Sambataro A, Baldi S, Modena V, Todros L, Libertucci D, Coni F, Fusaro E, Revello F, Murgia A, et al 1995 Primary biliary cirrhosis: lung involvement.
Liver 15: 196-201.
-
Coulouarn C, Gomez-Quiroz LE, Lee JS, Kaposi-Novak P, Conner EA, Goldina TA, Onishchenko GE, Factor VM, Thorgeirsson SS 2006 Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis.
Hepatology 44: 1003-1011.
*
-
Coverdale SA, Field J, Farrell GC 2003 How reversible is hepatic functional impairment in autoimmune hepatitis?
J. Gastroenterol. Hepatol. 18: 371-375.
*
-
Cox KL, Cox KM 1998 Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease.
J. Pediatr. Gastroenterol. Nutr. 27: 580-583.
-
Craven M, Simpson JW, Ridyard AE, Chandler ML 2004 Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002).
J. Small Anim. Pract. 45: 336-342.
-
Crestani M, Sadeghpour A, Stroup D, Galli G, Chiang JY 1998 Transcriptional activation of the cholesterol 7alpha-hydroxylase gene (CYP7A) by nuclear hormone receptors.
J. Lipid Res. 39: 2192-2200.
*
-
Cui FL, Fan J, Li W, Fan YC, Hu ZD 2004 Fluorescence spectroscopy studies on 5-aminosalicylic acid and zinc 5-aminosalylicylate interaction with human serum albumin.
J. Pharm. Biomed. Anal. 34: 189-197.
-
Cui Y, Konig J, Leier I, Buchholz U, Keppler D 2001 Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6.
J. Biol. Chem. 276: 9626-9630.
*
-
Cukovic-Cavka S 2004 Diffuse jejunoileitis in an adolescent.
Falk Symposium 140. Inflammatory Bowel Disease: Translation from Basic Research to Clinical Practice. Dubrovnik (Croatia). p. 69. May 7-8. *
-
Cyganek K, Mirkiewicz-Sieradzka B, Malecki MT, Wolkow P, Skupien J, Bobrek J, Czogala M, Klupa T, Sieradzki J 2006 Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients.
Acta Diabetol. 43: 114-119.
*
-
Czaja AJ, Hay JE, Rakela J 1990 Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis.
Mayo Clin. Proc. 65: 23-30.
-
Czaja AJ, Wolf AM, Baggenstoss AH 1980 Clinical assessment of cirrhosis in severe chronic active liver disease: specificity and sensitivity of physical and laboratory findings.
Mayo Clin. Proc. 55: 360-364.
-
Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schirmacher P, Biesterfeld S, Galle PR, Lohse AW, Kanzler S 2006 Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.
J. Hepatol. 45: 419-428.
*
-
Czupryniak L, Mlynarski W, Pawlowski M, Saryusz-Wolska M, Borkowska A, Klich I, Bodalski J, Loba J 2008 Circadian blood pressure variation in normotensive type 2 diabetes patients and angiotensin converting enzyme polymorphism.
Diabetes Res. Clin. Pract. 80: 386-391.
-
da Silva MF, Nobrega A, Ribeiro RC, Levy MS, Ribeiro OG, Tambourgi DV, Sant'anna DA, da Silva AC 2006 Genetic selection for resistance or susceptibility to oral tolerance imparts correlation to both immunoglobulin E level and mast cell number phenotypes with a profound impact on the atopic potential of the individual.
Clin. Exp. Allergy 36: 1399-1407.
*
-
Dabos KJ, Newsome PN, Parkinson JA, Mohammed HH, Sadler IH, Plevris JN, Hayes PC 2004 Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure.
Transplantation 77: 200-205.
-
Dai Y, Liang YH, Xie PY, Chen BW, Liu XG 2005 Clinical analysis of primary biliary cirrhosis: a report of 42 cases.
Beijing Da Xue Xue Bao 37: 410-414.
-
Daperno M, Sostegni R, Scaglione N, Ercole E, Rigazio C, Rocca R, Pera A 2004 Outcome of a conservative approach in severe ulcerative colitis.
Dig. Liver Dis. 36: 21-28.
*
-
Das KM 2004 Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen.
J. Gastroenterol. Hepatol. 19: S290-S294. *
-
Das SN, Mohapatra B, Mohanty R, Dash PC, Kar K, Dash PK 2007 Malarial hepatitis as a component of multiorgan failure - a bad prognostic sign.
J. Indian Med. Assoc. 105: 247-250.
-
Dawes LG, Laut HC, Woodruff M 2007 Decreased bile acid synthesis with total parenteral nutrition.
Am. J. Surg. 194: 623-627.
*
-
Day CP 2003 Alcoholic steatohepatitis (ASH).
Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 85-86. October 17 - 19. *
-
De Angelis M, Rizzello CG, Scala E, De Simone C, Farris GA, Turrini F, Gobbetti M 2007 Probiotic preparation has the capacity to hydrolyze proteins responsible for wheat allergy.
J. Food Prot. 70: 135-144.
-
de la Serna J, Montesinos P, Vellenga E, Rayon C, Parody R, Leon A, Esteve J, Bergua JM, Milone G, Deben G, Rivas C, Gonzalez M, Tormo M, Diaz-Mediavilla J, Gonzalez JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA 2008 Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
Blood 111: 3395-3402.
*
-
de Luis DA, Gonzalez Sagrado M, Vallejo LA, Gil Carcedo LM, Izaola O, Cuellar L, Terroba MC, Aller R 2007 Influence of G308A polymorphism of tumor necrosis factor-alpha gene on inflammatory markers in postsurgical head and neck cancer patients with early enteral nutrition.
Nutrition 23: 529-532.
-
de Man RA 1997 Severe hepatitis attributed to paroxetine (Seroxat).
Ned. Tijdschr. Geneeskd. 141: 540-542.
-
De Matos V, Russo PA, Cohen AB, Mamula P, Baldassano RN, Piccoli DA 2008 Frequency and clinical correlations of granulomas in children with Crohn disease.
J. Pediatr. Gastroenterol. Nutr. 46: 392-398.
-
de Medeiros FS, Tavares-Neto J, D'Oliveira A Jr, Parana R 2007 Liver injury in visceral leishmaniasis in children: systematic review.
Acta Gastroenterol. Latinoam. 37: 150-157.
-
Deems RO, Friedman LS, Friedman MI, Munoz SJ, Deems DA, Maddrey WC 1994 Relationship between liver biochemical tests and dietary intake in patients with liver disease.
J. Clin. Gastroenterol. 18: 304-308.
-
Del Compare ME, D'Agostino D, Ferraris JR, Boldrini G, Waisman G, Krmar RT 2004 Twenty-four-hour ambulatory blood pressure profiles in liver transplant recipients.
Pediatr. Transplant. 8: 496-501.
*
-
Demirkiran A, Bosma BM, Kok A, Baan CC, Metselaar HJ, Ijzermans JN, Tilanus HW, Kwekkeboom J, van der Laan LJ 2007 Allosuppressive donor CD4+CD25+ regulatory T cells detach from the graft and circulate in recipients after liver transplantation.
J. Immunol. 178: 6066-6072.
*
-
Derkow K, Loddenkemper C, Mintern J, Kruse N, Klugewitz K, Berg T, Wiedenmann B, Ploegh HL, Schott E 2007 Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis.
Hepatology 46: 1155-1165.
-
Desai CS, Josh AG, Abraham P, Desai DC, Deshpande RB, Bhaduri A, Shah SR 2006 Hepatic tuberculosis in absence of disseminated abdominal tuberculosis.
Ann. Hepatol. 5: 41-43.
-
Deschenes M, Villeneuve JP, Dagenais M, Fenyves D, Lapointe R, Pomier-Layrargues G, Roy A, Willems B, Marleau D 1997 Lack of relationship between preoperative measures of the severity of cirrhosis and short-term survival after liver transplantation.
Liver Transpl. Surg. 3: 532-537.
-
Deurloo DT, van Berkel MA, van Esch BC, Hofhuis F, Nijkamp FP, Oosterwegel MA, van Oosterhout AJ 2003 CD28/CTLA4 double deficient mice demonstrate crucial role for B7 co-stimulation in the induction of allergic lower airways disease.
Clin. Exp. Allergy 33: 1297-1304.
*
-
Deurloo DT, van Esch BC, Hofstra CL, Nijkamp FP, van Oosterhout AJ 2001 CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model.
Am. J. Respir. Cell. Mol. Biol. 25: 751-760.
*
-
Deveci F, Muz MH, Ilhan N, Kirkil G, Turgut T, Akpolat N 2008 Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma.
Respirology 13: 488-497.
-
Di Campli C, Gasbarrini G, Gasbarrini A 2003 Review article: a medicine based on cell transplantation - is there a future for treating liver diseases?
Aliment. Pharmacol. Ther. 18: 473-480.
*
-
Di Stefano G, Derenzini M, Kratz F, Lanza M, Fiume L 2004 Liver-targeted doxorubicin: effects on rat regenerating hepatocytes.
Liver Int. 24: 246-252.
*
-
Diaz FJ, Davalos MM, Roman VR, Bustios SC, Zumaeta VE 2004 Hepatotoxicity and pancreatitis associated with gold salts: case report.
Rev. Gastroenterol. Peru 24: 353-356.
-
Dibble JB, Sheridan P, Losowsky MS 1984 A survey of vitamin D deficiency in gastrointestinal and liver disorders.
Q. J. Med. 53: 119-134.
-
Dijkstra IM, de Haas AH, Brouwer N, Boddeke HW, Biber K 2006 Challenge with innate and protein antigens induces CCR7 expression by microglia in vitro and in vivo.
Glia 54: 861-872.
-
Dirkx R, Vanhorebeek I, Martens K, Schad A, Grabenbauer M, Fahimi D, Declercq P, Van Veldhoven PP, Baes M 2005 Absence of peroxisomes in mouse hepatocytes causes mitochondrial and ER abnormalities.
Hepatology 41: 868-878.
*
-
Diwakar V, Pearson L, Beath S 2001 Liver disease in children with cystic fibrosis.
Paediatr. Respir. Rev. 2: 340-349.
-
Djukanovic R 2000 The role of co-stimulation in airway inflammation.
Clin. Exp. Allergy 30 Suppl. 1: 46-50.
-
Djuric Z, Zivic S, Katic V 2007 Celiac disease with diffuse cutaneous vitamin K-deficiency bleeding.
Adv. Ther. 24: 1286-1289.
-
Doise JM, Aho LS, Quenot JP, Guilland JC, Zeller M, Vergely C, Aube H, Blettery B, Rochette L 2008 Plasma antioxidant status in septic critically ill patients: a decrease over time.
Fundam. Clin. Pharmacol. 22: 203-209.
*
-
Doria AS, Karshafian R, Moineddin R, Mohanta A, Zhong A, Mendes M, Pritzker K, Jong R, Burns P 2006 Contrast-enhanced triggered harmonic sonography for assessment of periarticular hemodynamic changes in experimental arthritis.
Pediatr. Radiol. 36: 1242-1251.
-
Doria C, Doyle HR, Mandala L, Marino IR, Caruana G, Gruttadauria S, Lauro A, Magnone M, Scotti Foglieni C, Lamonaca V, Scott VL 2003 Changes in serum electrolytes during treatment of patients in liver failure with molecular adsorbent recirculating system.
Int. J. Artif. Organs 26: 918-923.
-
Dray X, Joly F, Lavergne-Slove A, Treton X, Bouhnik Y, Messing B 2006 A severe but reversible refractory sprue.
Gut 55: 1210-1211.
*
-
Drivdal M, Trydal T, Hagve TA, Bergstad I, Aagenaes O 2006 Prognosis, with evaluation of general biochemistry, of liver disease in lymphoedema cholestasis syndrome 1 (LCS1/Aagenaes syndrome).
Scand. J. Gastroenterol. 41: 465-471.
*
-
Duan RS, Link H, Xiao BG 2005 Long-term effects of IFN-gamma, IL-10, and TGF-beta-modulated dendritic cells on immune response in Lewis rats.
J. Clin. Immunol. 25: 50-56.
*
-
Dufek M, Hamanova M, Lokaj J, Goldemund D, Rektorova I, Michalkova Z, Sheardova K, Rektor I 2008 Serum inflammatory biomarkers in Parkinson's disease.
Parkinsonism Relat. Disord. Jul 29 [Epub ahead of print].
-
Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB 2000 Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.
Clin. Chem. 46: 2027-2049.
*
-
Dufour JF, DeLellis R, Kaplan MM 1997 Reversibility of hepatic fibrosis in autoimmune hepatitis.
Ann. Intern. Med. 127: 981-985.
-
Dumasia R, Eagle KA, Kline-Rogers E, May N, Cho L, Mukherjee D 2005 Role of PPAR- gamma agonist thiazolidinediones in treatment of pre-diabetic and diabetic individuals: a cardiovascular perspective.
Curr. Drug Targets Cardiovasc. Haemato. Disord. 5: 377-386.
-
DuPont HL, Garey K, Caeiro JP, Jiang ZD 2008 New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control.
Curr. Opin. Infect. Dis. 21: 500-507.
-
Ebert EC, Geng X, Lin J, Das KM 2006 Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis.
Cell. Immunol. 244: 43-49.
*
-
Eckhoff DE, Pirsch JD, D'Alessandro AM, Knechtle SJ, Young CJ, Geffner SR, Belzer FO, Kalayoglu M 1995 Pretransplant status and patient survival following liver transplantation.
Transplantation 60: 920-925.
-
Edelman DA, Jiang Y, Tyburski JG, Wilson RF, Steffes CP 2007 Lipopolysaccharide activation of pericyte's Toll-like receptor-4 regulates co-culture permeability.
Am. J. Surg. 193: 730-735.
*
-
Eivindson M, Gronbaek H, Flyvbjerg A, Frystyk J, Zimmermann-Nielsen E, Dahlerup JF 2007 The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
Growth Horm. IGF Res. 17: 33-40.
-
Eivindson M, Gronbaek H, Skogstrand K, Thorsen P, Frystyk J, Flyvbjerg A, Dahlerup JF 2007 The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease.
Scand. J. Gastroenterol. 42: 464-470.
*
-
Eivindson M, Nielsen JN, Gronbaek H, Flyvbjerg A, Hey H 2005 The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease.
Horm. Res. 64: 9-15.
-
Ekstrom GM, Andersson SE 2000 Plasma exudation, hyperaemia, and epithelial permeability in rats with oxazolone-induced colitis: modulatory effects of budesonide.
Scand. J. Gastroenterol. 35: 190-197.
*
-
El Moutawakil B, Rafai MA, Gam I, Tahiri JM, Rhimou A, Slassi I 2007 Crohn's disease presenting with reccurent acute polyradiculoneuropathy.
Rev. Neurol. (Paris) 163: 244-246.
-
Elamanchili P, Lutsiak CM, Hamdy S, Diwan M, Samuel J 2007 "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
J. Immunother. 30: 378-395.
-
Elia PP, Fogaca HS, Barros RG, Zaltman C, Elia CS 2007 Descriptive analysis of the social, clinical, laboratorial and anthropometric profiles of inflammatory bowel disease inwards patients from the "Clementino Fraga Filho" University Hospital, Rio de Janeiro, RJ, Brazil.
Arq. Gastroenterol. 44: 332-339.
-
Elloumi H, Ben Abdelaziz A, Sfar S, Arfaoui D, Ben Slama A, Ghouma M, Ajmi S 2006 Predictive factors of intestinal stenosis in Crohn's disease.
Tunis. Med. 84: 711-713.
-
Engwegen JY, Helgason HH, Cats A, Harris N, Bonfrer JM, Schellens JH, Beijnen JH 2006 Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
World J. Gastroenterol. 12: 1536-1544.
*
-
Epstein CM, Riether AM, Henderson RM, Cotsonis GA 1992 EEG in liver transplantation: visual and computerized analysis.
Electroencephalogr. Clin. Neurophysiol. 83: 367-371.
-
Epstein O, Arborgh B, Sagiv M, Wroblewski R, Scheuer PJ, Sherlock S 1981 Is copper hepatotoxic in primary biliary cirrhosis?
J. Clin. Pathol. 34: 1071-1075.
*
-
Ernst B, Thurnheer M, Schmid SM, Schultes B 2008 Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery.
Obes. Surg. May 20 [Epub ahead of print].
-
Ertekin V, Selimoglu MA, Turkan Y, Akcay F 2005 Serum nitric oxide levels in children with celiac disease.
J. Clin. Gastroenterol. 39: 782-785.
-
Erzin Y, Uzun H, Celik AF, Aydin S, Dirican A, Uzunismail H 2008 Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
J. Clin. Gastroenterol. 42: 481-486.
-
Evenepoel P, Bammens B, Nevens F, Wilmer A, Vanrenterghem Y 2005 The molecular adsorbent recycling system (MARS) and transmembrane transport of albumin-bound toxins.
Liver Transpl. 11: 853-854.
*
-
Evenepoel P, Laleman W, Wilmer A, Claes K, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y 2006 Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
Artif. Organs 30: 276-284.
*
-
Evenepoel P, Laleman W, Wilmer A, Claes K, Maes B, Kuypers D, Bammens B, Nevens F, Vanrenterghem Y 2005 Detoxifying capacity and kinetics of Prometheus - a new extracorporeal system for the treatment of liver failure.
Blood Purif. 23: 349-358.
-
Ezzidi I, Mtiraoui N, Kacem M, Mallat SG, Mohamed MB, Chaieb M, Mahjoub T, Almawi WY 2008 Interleukin-10 -592C/A, -819C/T, and -1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes patients.
Clin. Endocrinol. (Oxf.) Jun 27 [Epub ahead of print].
-
Ezzidi I, Mtiraoui N, Mohamed MB, Mahjoub T, Kacem M, Almawi WY 2008 Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy.
J. Diabetes Complications 22: 331-338.
-
Faguer S, Kamar N, Boulestin A, Esposito L, Durand D, Blancher A, Rostaing L 2008 Prevalence of cryoglobulinemia and autoimmunity markers in renal-transplant patients.
Clin. Nephrol. 69: 239-243.
-
Fang WH, Yao YM, Shi ZG, Yu Y, Wu Y, Lu LR, Sheng ZY 2001 Effect of recombinant bactericidal/permeability-increasing protein on endotoxin translocation and lipopolysaccharide-binding protein/CD14 expression in rats after thermal injury.
Crit. Care Med. 29: 1452-1459.
-
Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C 2004 Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.
Hepatology 40: 820-826.
*
-
Fawcett RS, Linford S, Stulberg DL 2004 Nail abnormalities: clues to systemic disease.
Am. Fam. Physician 69: 1417-1424.
*
-
Faybik P, Hetz H 2006 Plasma disappearance rate of indocyanine green in liver dysfunction.
Transplant. Proc. 38: 801-802.
*
-
Faybik P, Krenn CG, Baker A, Lahner D, Berlakovich G, Steltzer H, Hetz H 2004 Comparison of invasive and noninvasive measurement of plasma disappearance rate of indocyanine green in patients undergoing liver transplantation: a prospective investigator-blinded study.
Liver Transpl. 10: 1060-1064.
*
-
Fellah H, Omar S, Feki M, Abderrahim E, Abdallah TB, Massy ZA, Lacour B, Maiz HB, Kaabachi N, Mebazaa A 2008 Is serum transthyretin a reliable marker of nutritional status in patients with end-stage renal disease?
Clin. Biochem. 41: 493-497.
-
Felldin M, Friman S, Olausson M, Backman L, Castedal M, Larsson B, Henriksson BA, Siewert-Delle A 2003 Liver dialysis using MARS in acute hepatic failure. Promising results in a pilot setting.
Lakartidningen 100: 3836-3838, 3841.
-
Fernandez J, Navasa M, Garcia-Pagan JC, G-Abraldes J, Jimenez W, Bosch J, Arroyo V 2004 Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
J. Hepatol. 41: 384-390.
*
-
Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, Esteve M, Gonzalez-Huix F, Gassull MA 1989 Vitamin status in patients with inflammatory bowel disease.
Am. J. Gastroenterol. 84: 744-748.
-
Fernandez-Banares F, Mingorance MD, Esteve M, Cabre E, Lachica M, Abad-Lacruz A, Gil A, Humbert P, Boix J, Gassull MA 1990 Serum zinc, copper, and selenium levels in inflammatory bowel disease: effect of total enteral nutrition on trace element status.
Am. J. Gastroenterol. 85: 1584-1589.
-
Ferrante M, Penninckx F, De Hertogh G, Geboes K, D'Hoore A, Noman M, Vermeire S, Rutgeerts P, Van Assche G 2006 Protein-losing enteropathy in Crohn's disease.
Acta Gastroenterol. Belg. 69: 384-389.
-
Ferrari D, Cysneiros RM, Scorza CA, Arida RM, Cavalheiro EA, de Almeida AC, Scorza FA 2008 Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: quantification with immunohistochemical for calcium-binding proteins.
Epilepsy Behav. 13: 36-42.
-
Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, Verucchi G, Cassani F, Chiodo F, Bianchi FB 2004 Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type.
QJM 97: 407-412.
*
-
Filippi C, Keatch SA, Rangar D, Nelson LJ, Hayes PC, Plevris JN 2004 Improvement of C3A cell metabolism for usage in bioartificial liver support systems.
J. Hepatol. 41: 599-605.
*
-
Finco C, Magnanini P, Sarzo G, Vecchiato M, Luongo B, Savastano S, Bortoliero M, Barison P, Merigliano S 2007 Prospective randomized study on perioperative enteral immunonutrition in laparoscopic colorectal surgery.
Surg. Endosc. 21: 1175-1179.
*
-
Finotto S, Eigenbrod T, Karwot R, Boross I, Doganci A, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Galle PR, Neurath MF 2007 Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
Int. Immunol. 19: 685-693.
-
Fiorentini MT, Locatelli L, Ceccopieri B, Bertolino F, Ostellino O, Barlotta A, Rolfo P, Ferraris R, de la Pierre M, Dellepiane M 1987 Physiology of ileoanal anastomosis with ileal reservoir for ulcerative colitis and adenomatosis coli.
Dis. Colon Rectum 30: 267-272.
-
Fisher L, Fisher A 2007 Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.
Clin. Gastroenterol. Hepatol. 5: 513-520.
-
Fiume L, Bolondi L, Busi C, Chieco P, Kratz F, Lanza M, Mattioli A, Di Stefano G 2005 Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine.
J. Hepatol. 43: 645-652.
*
-
Fletcher MA, McKenna TM, Quance JL, Wainwright NR, Williams TJ 1993 Lipopolysaccharide detoxification by endotoxin neutralizing protein.
J. Surg. Res. 55: 147-154.
-
Flisiak R, Pelszynska M, Prokopowicz D, Rogalska M, Grygoruk U 2005 High concentration of antimitochondrial antibodies predicts progressive primary biliary cirrhosis.
World J. Gastroenterol. 11: 5706-5709.
*
-
Floreani A, Mega A, Camozzi V, Baldo V, Plebani M, Burra P, Luisetto G 2005 Is osteoporosis a peculiar association with primary biliary cirrhosis?
World J. Gastroenterol. 11: 5347-5350.
*
-
Forsythe P, Inman MD, Bienenstock J 2007 Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice.
Am. J. Respir. Crit. Care Med. 175: 561-569.
*
-
Fortun PJ, Hawkey CJ 2005 Nonsteroidal antiinflammatory drugs and the small intestine.
Curr. Opin. Gastroenterol. 21: 169-175.
-
Franco J, Saeian K 1999 Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
Curr. Gastroenterol. Rep. 1: 95-101.
-
Frebourg T, Delpech B, Bercoff E, Senant J, Bertrand P, Deugnier Y, Bourreille J 1986 Serum hyaluronate in liver diseases: study by enzymoimmunological assay.
Hepatology 6: 392-395.
-
Frey O, Petrow PK, Gajda M, Siegmund K, Huehn J, Scheffold A, Hamann A, Radbruch A, Brauer R 2005 The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells.
Arthritis Res. Ther. 7: R291-R301.
*
-
Freysdottir J, Hardardottir I, Gizurarson S, Vikingsson A 2007 Mucosal tolerance to KLH reduces BSA-induced arthritis in rats - an indication of bystander suppression.
J. Clin. Immunol. 27: 284-293.
*
-
Fukuda W, Yamazaki T, Akaogi T, Hayashi H, Kusakabe T, Tsubouchi Y, Kawahito Y, Inoue M, Yoshikawa T 2005 Malnutrition and disease progression in patients with rheumatoid arthritis.
Mod. Rheumatol. 15: 104-107.
-
Fukui H 2005 Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure.
Alcohol Clin. Exp. Res. 29: 172S-179S.
-
Fukutomi T, Sakamoto S, Isobe H, Sakai H, Masumoto A, Nawata H 1992 Clinical significance of the serum levels of the 7S domain of type IV collagen in patients with primary biliary cirrhosis.
J. Gastroenterol. Hepatol. 7: 596-601.
-
Funk GC, Doberer D, Osterreicher C, Peck-Radosavljevic M, Schmid M, Schneeweiss B 2005 Equilibrium of acidifying and alkalinizing metabolic acid-base disorders in cirrhosis.
Liver Int. 25: 505-512.
*
-
Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF 2005 PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
Wien. Klin. Wochenschr. 117: 707-710.
-
Gaede PH 2006 Intensified multifactorial intervention in patients with type 2 diabetes and microalbuminuria: rationale and effect on late-diabetic complications.
Dan. Med. Bull. 53: 258-284.
-
Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, Voll RE, Winkler T, Kuhn A, Kalden J, Kern P, Herrmann M 2007 Clearance deficiency and systemic lupus erythematosus (SLE).
J. Autoimmun. 28: 114-121.
-
Galbraith SS, Drolet BA, Kugathasan S, Paller AS, Esterly NB 2005 Asymptomatic inflammatory bowel disease presenting with mucocutaneous findings.
Pediatrics 116: e439-e444.
*
-
Gan JH, Zhou XQ, Qin AL, Luo EP, Zhao WF, Yu H, Xu J 2005 Hybrid artificial liver support system for treatment of severe liver failure.
World J. Gastroenterol. 11: 890-894.
*
-
Gao H, Fu W, Li R, Chen L, Ji Q, Zhang L, Huang G, He F 2006 Expression and purification of a soluble B lymphocyte stimulator mutant modified with the T-helper cell epitope.
Biotechnol. Lett. 28: 1649-1654.
*
-
Gao L, Tian X, Liu B, Zhang F 2008 The value of antinuclear antibodies in primary biliary cirrhosis.
Clin. Exp. Med. 8: 9-15.
*
-
Garcia CE, Garcia RF, Gunson B, Christensen E, Neuberger J, McMaster P, Mirza DF 2004 Analysis of marginal donor parameters in liver transplantation for primary biliary cirrhosis.
Exp. Clin. Transplant. 2: 183-188.
-
Garcia Ruiz P, Canora Lebrato J, Diez Ruiz A, Fuchs D, Wachter H 2004 Soluble interleukin-2 and tumor necrosis factor receptor in liver cirrhosis. Relationship with clinical severity and prognosis.
Med. Clin. (Barc.) 122: 441-443.
-
Garcia-Compean D, Blanc P, Larrey D, Daures JP, Hirtz J, Mendoza E, Maldonado H, Michel H 2002 Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial.
Ann. Hepatol. 1: 29-35.
*
-
Gariballa S 2008 Refeeding syndrome: a potentially fatal condition but remains underdiagnosed and undertreated.
Nutrition 24: 604-606.
*
-
Gartner U, Goeser T, Stiehl A, Raedsch R, Wolkoff AW 1990 Transport of chenodeoxycholic acid and its 3-alpha- and 7-alpha-sulfates by isolated perfused rat liver.
Hepatology 12: 738-742.
-
Gass J, Vora H, Hofmann AF, Gray GM, Khosla C 2007 Enhancement of dietary protein digestion by conjugated bile acids.
Gastroenterology 133: 16-23.
*
-
Gates AT, Fakayode SO, Lowry M, Ganea GM, Murugeshu A, Robinson JW, Strongin RM, Warner IM 2008 Gold nanoparticle sensor for homocysteine thiolactone-induced protein modification.
Langmuir 24: 4107-4113.
-
Gee JM, Kalil A, Thullbery M, Becker KJ 2008 Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke.
Stroke 39: 1575-1582.
-
Gee MI, Grace MG, Wensel RH, Sherbaniuk RW, Thomson AB 1985 Nutritional status of gastroenterology outpatients: comparison of inflammatory bowel disease with functional disorders.
J. Am. Diet. Assoc. 85: 1591-1599.
-
Gehling UM, Willems M, Dandri M, Petersen J, Berna M, Thill M, Wulf T, Muller L, Pollok JM, Schlagner K, Faltz C, Hossfeld DK, Rogiers X 2005 Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors.
J. Hepatol. 43: 845-853.
*
-
Gelbmann CM 2000 Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease - do we have reliable markers?
Inflamm. Bowel Dis. 6: 123-131.
*
-
Gentilini P, Bernardi M, Bolondi L, Craxi A, Gasbarrinie G, Ideo G, Laffi G, La Villa G, Salerno F, Ventura E, Pulazzini A, Segantini L, Romanelli RG 2004 The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards.
Dig. Liver Dis. 36: 539-546.
-
Gentilini P, Casini-Raggi V, Di Fiore G, Romanelli RG, Buzzelli G, Pinzani M, La Villa G, Laffi G 1999 Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial.
J. Hepatol. 30: 639-645.
*
-
George J 2004 Artificial liver support systems.
J. Assoc. Physicians India. 52: 719-722.
-
Gerbes AL, Gulberg V 2006 Progress in treatment of massive ascites and hepatorenal syndrome.
World J. Gastroenterol. 12: 516-519.
*
-
Gerhold K, Avagyan A, Seib C, Frei R, Steinle J, Ahrens B, Dittrich AM, Blumchen K, Lauener R, Hamelmann E 2006 Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice.
J. Allergy Clin. Immunol. 118: 666-673.
*
-
Gershonowitz A, Itach EG, Shouval D, Mitrani D, Ilan Y, Mitrani E 2004 Development of a scaled up liver device incorporating cryo-preserved pig liver micro-organs.
J. Hepatol. 41: 950-956.
*
-
Gerth AJ, Lin L, Neurath MF, Glimcher LH, Peng SL 2004 An innate cell-mediated, murine ulcerative colitis-like syndrome in the absence of nuclear factor of activated T cells.
Gastroenterology 126: 1115-1121.
*
-
Gertzberg N, Gurnani T, Neumann P, Forbes AK, Jean-Louis N, Johnson A 2007 Tumor necrosis factor-alpha causes barrier dysfunction mediated by tyrosine198 and tyrosine218 in beta-actin.
Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L1219-L1229.
*
-
Gervois P, Kleemann R, Pilon A, Percevault F, Koenig W, Staels B, Kooistra T 2004 Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate.
J. Biol. Chem. 279: 16154-1660.
*
-
Gharib AM, Thomasson D, Li KC 2004 Molecular imaging of hepatocellular carcinoma.
Gastroenterology 127 (5 Suppl. 2): S153-S158.
*
-
Ghirardi M, Di Fabio F, Mariani PP, Nascimbeni R, Salerni B 2003 Surgery in severe ulcerative colitis: our experience.
Ann. Ital. Chir. 74: 543-546.
-
Giannini L, Nistri S, Mastroianni R, Cinci L, Vannacci A, Mariottini C, Passani MB, Mannaioni PF, Bani D, Masini E 2008 Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs.
J. Cell. Mol. Med. Feb 4 [Epub ahead of print].
*
-
Giboney PT 2005 Mildly elevated liver transaminase levels in the asymptomatic patient.
Am. Fam. Physician 71: 1105-1110.
*
-
Gieni RS, Yang X, Kelso A, Hayglass KT 1996 Limiting dilution analysis of CD4 T-cell cytokine production in mice administered native versus polymerized ovalbumin: directed induction of T-helper type-1-like activation.
Immunology 87: 119-126.
*
-
Gindro T, Arrigoni A, Martinasso G, Rosina F, Perardi S, Cappello N, Benedetti P, Actis GC, Verme G, Rizzetto M 1997 Monoethyl glycine xylidide (MEGX) test evaluation in primary biliary cirrhosis: comparison with Mayo score.
Eur. J. Gastroenterol. Hepatol. 9: 1155-1159.
-
Gines P 2003 Refractory ascites and hepatorenal syndrome.
Falk Symposium 137. XII FALK LIVER WEEK 2003 (Part II) In honour of Hans Popper’s 100th Birthday. Liver Diseases: Advances in Treatment and Prevention. Freiburg (Germany). p. 97-98. October 17 - 19. *
-
Gines P, Guevara M, De Las Heras D, Arroyo V 2002 Review article: albumin for circulatory support in patients with cirrhosis.
Aliment. Pharmacol. Ther. 16 Suppl. 5: 24-31.
-
Gines P, Tito L, Arroyo V, Planas R, Panes J, Viver J, Torres M, Humbert P, Rimola A, Llach J, et al 1988 Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.
Gastroenterology 94: 1493-1502.
-
Glastras SJ, Craig ME, Verge CF, Chan AK, Cusumano JM, Donaghue KC 2005 The role of autoimmunity at diagnosis of type 1 diabetes in the development of thyroid and celiac disease and microvascular complications.
Diabetes Care 28: 2170-2175.
*
-
Goessling W, Zucker SD 2000 Role of apolipoprotein D in the transport of bilirubin in plasma.
Am. J. Physiol. Gastrointest. Liver Physiol. 279: G356-G365.
*
-
Goggins MG, Goh J, O'Connell MA, Weir DG, Kelleher D, Mahmud N 2001 Soluble adhesion molecules in inflammatory bowel disease.
Ir. J. Med. Sci. 170: 107-111.
-
Goggins MG, Shah SA, Goh J, Cherukuri A, Weir DG, Kelleher D, Mahmud N 2001 Increased urinary nitrite, a marker of nitric oxide, in active inflammatory bowel disease.
Mediators Inflamm. 10: 69-73.
*
-
Gomes Mde B 2006 Glitazones and the metabolic syndrome: mechanism of action, pathophysiology and therapeutic indications.
Arq. Bras. Endocrinol. Metabol. 50: 271-280.
-
Gomez-Vaquero C, Fiter J, Enjuanes A, Nogues X, Diez-Perez A, Nolla JM 2007 Influence of the BsmI polymorphism of the vitamin D receptor gene on rheumatoid arthritis clinical activity.
J. Rheumatol. 34: 1823-1826.
-
Gong Y, Christensen E, Gluud C 2007 Cyclosporin A for primary biliary cirrhosis.
Cochrane Database Syst. Rev. 3: CD005526.
*
-
Gonzalez-Huix F, Fernandez-Banares F, Esteve-Comas M, Abad-Lacruz A, Cabre E, Acero D, Figa M, Guilera M, Humbert P, de Leon R, et al 1993 Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis.
Am. J. Gastroenterol. 88: 227-232.
-
Goodman DS 1984 Overview of current knowledge of metabolism of vitamin A and carotenoids.
J. Natl. Cancer Inst. 73: 1375-1379.
-
Goodridge HS, McGuiness S, Houston KM, Egan CA, Al-Riyami L, Alcocer MJ, Harnett MM, Harnett W 2007 Phosphorylcholine mimics the effects of ES-62 on macrophages and dendritic cells.
Parasite Immunol. 29: 127-137.
*
-
Goodstadt L, Powell T, Figtree GA 2006 17beta-Estradiol potentiates the cardiac cystic fibrosis transmembrane conductance regulator chloride current in guinea-pig ventricular myocytes.
J. Physiol. Sci. 56: 29-37.
*
-
Gores GJ, Moore SB, Fisher LD, Powell FC, Dickson ER 1987 Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens.
Hepatology 7: 889-892.
-
Gray M, Miles K, Salter D, Gray D, Savill J 2007 Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells.
Proc. Natl. Acad. Sci. U.S.A. 104: 14080-14085.
*
-
Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G 2001 Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
Hepatology 33: 544-553.
*
-
Greupink R, Bakker HI, Reker-Smit C, van Loenen-Weemaes AM, Kok RJ, Meijer DK, Beljaars L, Poelstra K 2005 Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell.
J. Hepatol. 43: 884-892.
*
-
Grivceva Stardelova K, Misevska P, Zdravkovska M, Trajkov D, Serafimoski V 2008 Total parenteral nutrition in treatment of patients with inflammatory bowel disease.
Prilozi. 29: 21-43.
-
Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB 1989 Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.
Proc. Natl. Acad. Sci. U.S.A. 86: 6367-6371.
*
-
Guan Y 2004 Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.
J. Am. Soc. Nephrol. 15: 2801-2815.
*
-
Guanabens N, Pares A, Ros I, Caballeria L, Pons F, Vidal S, Monegal A, Peris P, Rodes J 2005 Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis.
J. Hepatol. 42: 573-577.
*
-
Gui GP, Thomas PR, Tizard ML, Lake J, Sanderson JD, Hermon-Taylor J 1997 Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics.
J. Antimicrob. Chemother. 39: 393-400.
*
-
Guichelaar MM, Kendall R, Malinchoc M, Hay JE 2006 Bone mineral density before and after OLT: long-term follow-up and predictive factors.
Liver Transpl. 12: 1390-1402.
*
-
Guillouzo A, Corlu A, Aninat C, Glaise D, Morel F, Guguen-Guillouzo C 2007 The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
Chem. Biol. Interact. 168: 66-73.
*
-
Gupta N, Bostrom AG, Kirschner BS, Ferry GD, Winter HS, Baldassano RN, Gold BD, Abramson O, Smith T, Cohen SA, Heyman MB 2007 Gender differences in presentation and course of disease in pediatric patients with Crohn disease.
Pediatrics 120: e1418-e1425.
*
-
Gupta N, Cohen SA, Bostrom AG, Kirschner BS, Baldassano RN, Winter HS, Ferry GD, Smith T, Abramson O, Gold BD, Heyman MB 2006 Risk factors for initial surgery in pediatric patients with Crohn's disease.
Gastroenterology 130: 1069-1077.
*
-
Gupta RC, Tan EM 1981 Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A.
Clin. Exp. Immunol. 46: 9-19.
*
-
Haagsma EB, Gips CH, Wesenhagen H, Van Imhoff GW, Krom RA 1985 Liver disease and its effect on haemostasis during liver transplantation.
Liver 5: 123-128.
-
Haapamaki MM, Gronroos J, Nurmi H, Irjala K, Peuravuori H, Nevalainen TJ 2006 Value of blood tests including serum group IIA phospholipase A2 and bactericidal/permeability-increasing protein in Crohn's disease.
Scand. J. Clin. Lab. Invest. 66: 585-594.
*
-
Haase C, Ejrnaes M, Juedes AE, Wolfe T, Markholst H, von Herrath MG 2005 Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo.
Blood 106: 4225-4233.
*
-
Hagiwara S, Makita Y, Gu L, Tanimoto M, Zhang M, Nakamura S, Kaneko S, Itoh T, Gohda T, Horikoshi S, Tomino Y 2006 Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
Nephrol. Dial. Transplant. 21: 605-615.
-
Hallgren R, Colombel JF, Dahl R, Fredens K, Kruse A, Jacobsen NO, Venge P, Rambaud JC 1989 Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents.
Am. J. Med. 86: 56-64.
-
Hamada M, Tokumoto Y, Furukawa S, Minami H, Hiasa Y, Michitaka K, Horiike N, Onji M 2004 Hepatopulmonary syndrome in a patient with primary biliary cirrhosis.
Intern. Med. 43: 458-460.
*
-
Hamm S, Heit A, Koffler M, Huster KM, Akira S, Busch DH, Wagner H, Bauer S 2007 Immunostimulatory RNA is a potent inducer of antigen-specific cytotoxic and humoral immune response in vivo.
Int. Immunol. 19: 297-304.
-
Hammana I, Malet A, Costa M, Brochiero E, Berthiaume Y, Potvin S, Chiasson JL, Coderre L, Rabasa-Lhoret R 2007 Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Diabetes Metab. 33: 213-219.
-
Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W 2008 Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
Semin. Ophthalmol. 23: 191-200.
-
Han SH, Lee OY, Eun CS, Roh BJ, Sohn W, Baeg SS, Yoon BC, Choi HS 2007 A case of protein-losing enteropathy associated with small bowel villous atrophy.
Korean J. Gastroenterol. 49: 31-36.
-
Hanif M, Raza J, Qureshi H, Issani Z 2004 Etiology of chronic liver disease in children.
J. Pak. Med. Assoc. 54: 119-122.
-
Hansen TK, Tarnow L, Thiel S, Steffensen R, Stehouwer CD, Schalkwijk CG, Parving HH, Flyvbjerg A 2004 Association between mannose-binding lectin and vascular complications in type 1 diabetes.
Diabetes 53: 1570-1576.
*
-
Hansen TK, Thiel S, Knudsen ST, Gravholt CH, Christiansen JS, Mogensen CE, Poulsen PL 2003 Elevated levels of mannan-binding lectin in patients with type 1 diabetes.
J. Clin. Endocrinol. Metab. 88: 4857-4861.
*
-
Hao S, Bai O, Li F, Yuan J, Laferte S, Xiang J 2007 Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity.
Immunology 120: 90-102.
*
-
Hardison WG, Hatoff DE, Miyai K, Weiner RG 1981 Nature of bile acid maximum secretory rate in the rat.
Am. J. Physiol. 241: G337-G343.
-
Harimoto N, Taketomi A, Kitagawa D, Kuroda Y, Itoh S, Giona T, Tanaka S, Shirabe K, Shimada M, Maehara Y 2005 The newly established human hepatocyte cell line: application for the bioartificial liver.
J. Hepatol. 42: 557-564.
*
-
Hariz MB, Kallel-Sellami M, Kallel L, Lahmer A, Halioui S, Bouraoui S, Laater A, Sliti A, Mahjoub A, Zouari B, Makni S, Maherzi A 2007 Prevalence of celiac disease in Tunisia: mass-screening study in schoolchildren.
Eur. J. Gastroenterol. Hepatol. 19: 687-694.
-
Harnett MM, Kean DE, Boitelle A, McGuiness S, Thalhamer T, Steiger CN, Egan C, Al-Riyami L, Alcocer MJ, Houston KM, Gracie JA, McInnes IB, Harnett W 2008 The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis.
Ann. Rheum. Dis. 67: 518-523.
-
Harnois DM, Angulo P, Jorgensen RA, LaRusso NF, Lindor KD 2001 High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
Am. J. Gastroenterol. 96: 1558-1562.
*
-
Harrison J, McKiernan J, Neuberger JM 1997 A prospective study on the effect of recipient nutritional status on outcome in liver transplantation.
Transpl. Int. 10: 369-374.
-
Harsha WT, Kalandarova E, McNutt P, Irwin R, Noel J 2006 Nutritional supplementation with transforming growth factor-beta, glutamine, and short chain fatty acids minimizes methotrexate-induced injury.
J. Pediatr. Gastroenterol. Nutr. 42: 53-58.
*
-
Harzallah F, Daoud I, Bouzid C, Oueslati A, Kanoun F, Slimane H 2006 Celiac disease revealed by hypocalcemia complicating total thyroidectomy: a case report.
Ann. Endocrinol. (Paris) 67: 357-359.
-
Hashmonai M, Kam I, Schramek A 1984 The etiology of "white bile" in the biliary tree.
J. Surg. Res. 37: 479-486.
-
Hatano T, Fukuda M, Shiotsuki H, Miwa H, Urabe T, Mizuno Y 2006 Chronic inflammatory demyelinating polyneuropathy followed by systemic lupus erythematosus and Sjogren syndrome: a case report.
Rinsho Shinkeigaku 46: 203-209.
-
Hayashi Y, Wang W, Ninomiya T, Nagano H, Ohta K, Itoh H 1999 Liver enriched transcription factors and differentiation of hepatocellular carcinoma.
Mol. Pathol. 52: 19-24.
*
-
He R, Oyoshi MK, Jin H, Geha RS 2007 Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge.
Proc. Natl. Acad. Sci. U.S.A. 40: 15817-15822.
*
-
Heathcote J 2004 Round table: classification of autoimmune liver diseases and diagnostic criteria. Overlap syndromes – don’t exist.
Falk Symposium 142: GASTROENTEROLOGY WEEK FREIBURG 2004 (Part I) AUTOIMMUNE LIVER DISEASE, Freiburg (Germany), October 12 - 13, 2004, pp. 61-62. *
-
Heathcote J, Ross A, Sherlock S 1976 A prospective controlled trial of azathioprine in primary biliary cirrhosis.
Gastroenterology 70: 656-660.
-
Heidelbaugh JJ, Sherbondy M 2006 Cirrhosis and chronic liver failure: part II. Complications and treatment.
Am. Fam. Physician 74: 767-776.
*
-
Helenius LM, Meurman JH, Helenius I, Kari K, Hietanen J, Suuronen R, Hallikainen D, Kautiainen H, Leirisalo-Repo M, Lindqvist C 2005 Oral and salivary parameters in patients with rheumatic diseases.
Acta Odontol. Scand. 63: 284-293.
-
Hellings PW, Vandenberghe P, Kasran A, Coorevits L, Overbergh L, Mathieu C, Ceuppens JL 2002 Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice.
Eur. J. Immunol. 32: 585-594.
*
-
Hendrickse MT, Triger DR 1993 Autonomic and peripheral neuropathy in primary biliary cirrhosis.
J. Hepatol. 19: 401-407.
-
Heo J, Factor VM, Uren T, Takahama Y, Lee JS, Major M, Feinstone SM, Thorgeirsson SS 2006 Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver.
Hepatology 44: 1478-1486.
*
-
Hernandez G, Velasco N, Wainstein C, Castillo L, Bugedo G, Maiz A, Lopez F, Guzman S, Vargas C 1999 Gut mucosal atrophy after a short enteral fasting period in critically ill patients.
J. Crit. Care 14: 73-77.
-
Herold C, Ganslmayer M, Deynet C, Hahn EG, Schuppan D 2002 Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis.
Liver 22: 159-165.
-
Heseltine L, Turner IB, Fussey SP, Kelly PJ, James OF, Yeaman SJ, Bassendine MF 1990 Primary biliary cirrhosis. Quantitation of autoantibodies to purified mitochondrial enzymes and correlation with disease progression.
Gastroenterology 99: 1786-1792.
-
Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R 1995 Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hepatology 22: 82-87.
-
Hino A, Kweon MN, Fujihashi K, McGhee JR, Kiyono H 2004 Pathological role of large intestinal IL-12p40 for the induction of Th2-type allergic diarrhea.
Am. J. Pathol. 164: 1327-1335.
*
-
Hinson RM, Williams JA, Shacter E 1996 Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.
Proc. Natl. Acad. Sci. U.S.A. 93: 4885-4890.
*
-
Hirota T, Suzuki E, Ito I, Ishiyama M, Goto S, Horikawa Y, Asano T, Kanematsu M, Hoshi H, Takeda J 2008 Coronary artery calcification, arterial stiffness and renal insufficiency associate with serum levels of tumor necrosis factor-alpha in Japanese type 2 diabetic patients.
Diabetes Res. Clin. Pract. Jun 21 [Epub ahead of print].
-
Ho GT, Mowat C, Goddard CJ, Fennell JM, Shah NB, Prescott RJ, Satsangi J 2004 Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery.
Aliment. Pharmacol. Ther. 19: 1079-1087.
*
-
Hoda KM, Collins JF, Knigge KL, Deveney KE 2008 Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review.
Dis. Colon Rectum 51: 554-560.
*
-
Hofer SE, Bennetts B, Chan AK, Holloway B, Karschimkus C, Jenkins AJ, Silink M, Donaghue KC 2006 Association between PON 1 polymorphisms, PON activity and diabetes complications.
J. Diabetes Complications 20: 322-328.
-
Hofmann AF 2002 Cholestatic liver disease: pathophysiology and therapeutic options.
Liver 22 Suppl. 2: 14-19.
-
Hoier-Madsen M, Holm J, Hansen SI, Nielsen OH 1989 Serum antibodies to cow's milk folate-binding protein in patients with chronic inflammatory bowel disease.
Int. J. Tissue React. 11: 327-332.
-
Holland N, Dong J, Garnett E, Shaikh N, Huen K, Harmatz P, Olive A, Winter HS, Gold BD, Cohen SA, Baldassano RN, Kirschner BS, Heyman MB 2008 Reduced intracellular T-helper 1 interferon-gamma in blood of newly diagnosed children with Crohn's disease and age-related changes in Th1/Th2 cytokine profiles.
Pediatr. Res. 63: 257-262.
-
Holloway MG, Cui Y, Laz EV, Hosui A, Hennighausen L, Waxman DJ 2007 Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus.
Endocrinology 148: 1977-1986.
*
-
Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, Lu L, Ufret RL, Salomon RG, Perez VL 2008 Oxidative damage-induced inflammation initiates age-related macular degeneration.
Nat. Med. 14: 194-198.
*
-
Holmkvist J, Cervin C, Lyssenko V, Winckler W, Anevski D, Cilio C, Almgren P, Berglund G, Nilsson P, Tuomi T, Lindgren CM, Altshuler D, Groop L 2006 Common variants in HNF-1 alpha and risk of type 2 diabetes.
Diabetologia 49: 2882-2891.
*
-
Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, Park HK, Han H, Kim H 2005 In vitro differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocyte-like cells.
Biochem. Biophys. Res. Commun. 330: 1153-1161.
*
-
Hoofnagle JH, Davis GL, Schafer DF, Peters M, Avigan MI, Pappas SC, Hanson RG, Minuk GY, Dusheiko GM, Campbell G, et al 1986 Randomized trial of chlorambucil for primary biliary cirrhosis.
Gastroenterology 91: 1327-1334.
-
Horie H, Okada M, Kojima M, Nagai H 2006 Favorable effects of preoperative enteral immunonutrition on a surgical site infection in patients with colorectal cancer without malnutrition.
Surg. Today 36: 1063-1068.
*
-
Hosokawa A, Takahashi H, Akaike J, Okuda H, Murakami R, Kawahito Y, Tokuno T, Makiguchi Y, Sakamoto H, Hinoda Y, Imai K 1998 A case of Sjogren's syndrome associated with inflammatory pseudotumor of the liver.
Nihon Rinsho Meneki Gakkai Kaishi 21: 226-233.
-
Hosoyamada T 2006 Clinical studies of pediatric malabsorption syndromes.
Fukuoka Igaku Zasshi 97: 322-350.
-
Hou G, Dick R, Zeng C, Brewer GJ 2007 Antitumor and antiinflammatory effects of tetrathiotungstate in comparison with tetrathiomolybdate.
Transl. Res. 149: 260-264.
*
-
Hovind P, Lamberts S, Hop W, Deinum J, Tarnow L, Parving HH, Janssen JA 2007 An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetes.
Eur. J. Endocrinol. 156: 83-90.
*
-
Hreha G, Jefferson DM, Yu CH, Grubman SA, Alsabeh R, Geller SA, Vierling JM 1999 Immortalized intrahepatic mouse biliary epithelial cells: immunologic characterization and immunogenicity.
Hepatology 30: 358-371.
*
-
Hsiang CH, Marten NW, Straus DS 1999 Upstream region of rat serum albumin gene promoter contributes to promoter activity: presence of functional binding site for hepatocyte nuclear factor-3.
Biochem. J. 338: 241-249.
*
-
Hu BC, Chu SL, Wang GL, Gao PJ, Zhu DL, Wang JG 2008 Association between genetic variation in transforming growth factors beta1 and beta3 and renal dysfunction in non-diabetic Chinese.
Clin. Exp. Hypertens. 30: 121-131.
-
Huang H, Hao S, Li F, Ye Z, Yang J, Xiang J 2007 CD4+ Th1 cells prom
| |
